Women's Interagency Hiv Study Drug List 1

Women's Interagency Hiv Study Drug List 1

WOMEN’S INTERAGENCY HIV STUDY DRUG LIST 1 – BY ALPHABET 204 = 3‐TC (Epivir, lamivudine) 163 = dideoxyandenosine (ddA) 218 = abacavir (Ziagen) 094 = dideoxycytidine (ddC, zalcitabine, Hivid) 300 = Abacavir/lamivudine + Cabotegravir 147 = dideoxyinosine (ddI, didanosine, Videx, Videx EC) (GSK1265744) followed by intramuscular 286 = dolutegravir (Tivicay, S/GSK1349572) regimen of Cabotegravir + Rilpirivine (TMC278) 307 = dolutegravir + lamivudine dual therapy treatment 285 = ACTG A5303 (Prezista, Norvir, Emtriva + Viread 207 = Droxia (hydroxyurea, Hydrea) and Selzentry blinded trial) 276 = Edurant (rilpivirine, TMC 278) 146 = acyclovir (Zovirax) 220 = efavirenz (Sustiva) 224 = adefovir (Preveon) 284 = elvitegravir (Vitekta) 219 = Agenerase (amprenavir) 268 = elvitegravir (GS‐9137) blinded trial 090 = alpha interferon 278 = elvitegravir + cobicistat booster (blinded trial) 101 = Ampligen 221 = emivirine (Coactinon) 219 = amprenavir (Agenerase) 239 = emtricitabine (Emtriva, Corviracil, FTC) 238 = Aptivus (tipranavir) 239 = Emtriva (emtricitabine, Coviracil, FTC) 243 = atazanavir (Reyataz) 285 = Emtriva, Norvir, Prezista + Viread and Selzentry 262 = Atripla (Sustiva + Viread + Emtriva, efavirenz + blinded trial (ACTG A5303) tenofovir + emtricitabine) 233 = ENF (enfuvirtide, Fuzeon, T‐20) 092 = AZT (Retrovir, zidovudine) 233 = enfuvirtide (Fuzeon, T‐20, ENF) 122 = beta interferon 204 = Epivir (3‐TC, lamivudine) 263 = brecanavir (GW640385) 254 = Epzicom (abacabir sulfate + lamivudine, Ziagen + 128 = CD4 Epivir) 297 = cabotegravir (GSK1265744) 255 = etravirine (Intelence, TMC 125) 300 = Cabotegravir (GSK1265744) + 296 = Evotaz (atazanavir + cobicistat) Abacavir/lamivudine followed by intramuscular 210 = Fortovase (saquinavir, Invirase) regimen of Cabotegravir + Rilpirivine (TMC278) 249 = fosamprenavir (Lexiva) 298 = cenicriviroc/EFV 239 = FTC (Emtriva, emtricitabine, Corviracil) 231 = cidofovir (Vistide) 233 = Fuzeon (enfuvirtide, T‐20, ENF) 221 = coactinon (emivirine) 290 = Genvoya (EVG + cobicistat + FTC + TAF) 283 = cobicistat (GS‐9350) 297 = GSK1265744 (cabotegravir) 282 = cobicistat‐boosted darunavir (blinded trial 284 = GS‐9137 (elvitegravir) comparing cobicistat‐boosted darunavir to 268 = GS‐9137 (elvitegravir) blinded trial ritonavir‐boosted darunavir) 283 = GS‐9350 (Cobicistat) 227 = Combivir (AZT + 3TC, Retrovir + Epivir) 292 = GS‐US‐216‐0130 (DRV + cobicistat + 2 NRTIs) 280 = Complera (emtricitabine + rilpivirine + tenofovir) 289 = GS‐US‐292‐0102 (EVG + cobicistat + FTC + TAF) 239 = Corviracil (Emtriva, emtricitabine, FTC) blinded trial 212 = Crixivan (indinavir) 291 = GS‐US‐299‐0102 (DRV + cobicistat + FTC + TAF) 159 = d4T (Zerit, stavudine) 294 = GS‐US‐311‐1089 (blinded FTC + TDF or FTC + TAF) 163 = ddA (dideoxyandenosine) 304 = GS‐US‐311‐1717 (ABC + 3TC or FTC + TAF) blinded 094 = ddC (dideoxycytidine, zalcitabine, Hivid) 302 = GS‐US‐366‐1160 (FTC + RPV + TAF or EFV + FTC + 147 = ddI (dideoxyinosine, didanosine, Videx, Videx EC) TDF (Atripla)) blinded 244 = DPC 083 303 = GS‐US‐366‐1216 (FTC + RPV + TAF or FTC + RPV + 256 = darunavir (Prezista, TMC‐114) TDF (Complera)) blinded 194 = delavirdine (Rescriptor) 263 = GW640385 (brecanavir) 308 = Descovy (FTC + TAF) 094 = Hivid (ddC, dideoxycytidine, zalcitabine) 110 = dextran‐sulfate 056 = HPA‐23 (ammonium‐21‐tungsto‐9‐anti‐moniate) 147 = didanosine (ddI, dideoxyinosine, Videx, Videx EC) 207 = Hydrea (hydroxyurea, Droxia) WIHS Drug List 1 – 04/01/2016a Page 1 of 4 WOMEN’S INTERAGENCY HIV STUDY DRUG LIST 1 – BY ALPHABET 207 = hydroxyurea (Droxia, Hydrea) 266 = SCH‐417690 (vicriviroc) 212 = indinavir (Crixivan) 258 = SP01A (Samaritan Pharma oral entry inhibitor) 255 = Intelence (etravirine, TMC 125) 258 = Samaritan Pharma oral entry inhibitor (SP01A) 210 = Invirase (saquinavir, Fortovase) 210 = saquinavir (Invirase, Fortovase) 264 = Isentress (raltegravir, MK 0518) 265 = Selzentry (maraviroc, UK‐427, 857) 055 = Isoprinosine 159 = stavudine (Zerit, d4T) 217 = Kaletra (lopinavir/ritonavir) 287 = Stribild (FTC + Viread + EVG + cobicistat) 257 = L‐00870810 (Merck integrase inhibitor) 057 = suramin 204 = lamivudine (3‐TC, Epivir) 220 = Sustiva (efavirenz, DMP266) 307 = lamivudine + dolutegravir dual therapy treatment 233 = T‐20 (enfuvirtide, Fuzeon, ENF) 249 = Lexiva (fosamprenavir) 305 = TAF (tenofovir alafenamide) 222 = lobucavir 192 = TAT inhibitors 217 = lopinavir/ritonavir (Kaletra) 299 = TMC114IFD3013 223 = loviride 267 = TMC278 blinded trial 265 = maraviroc (Selzentry, UK‐427, 857) 305 = tenofovir alafenamide (TAF) 257 = Merck integrase inhibitor (L‐00870810) 234 = Tenofovir disoproxil (adenine fumarate, Viread) 216 = nelfinavir (Viracept) 238 = tipranavir (Aptivus) 191 = nevirapine (Viramune) 286 = Tivicay (dolutegravir, S/GSK1349572) 211 = Norvir (ritonavir) 293 = Triumeq (DTG + ABC + 3TC) 285 = Norvir, Prezista, Emtriva + Viread and Selzentry 240 = Trizivir (abacavir + zidovudine + lamivudine, ABC + blinded trial (ACTG A5303) AZT + 3TC) 306 = Odefsey (FTC + RPV + TAF) 253 = Truvada (tenofovir disoproxil fumarate + 998 = Other antiviral emtricitabine, Viread + Emtriva, TDF + FTC) 193 = Other protease inhibitors 999 = Unknown antiviral 108 = Peptide T 266 = vicriviroc (SCH‐417690) 224 = Preveon (adefovir) 269 = vicriviroc blinded trial 295 = Prezcobix (darunabir + cobicistat) 179 = Vidarabine (adenosine arabinoside) 256 = Prezista (darunavir, TMC‐114) 147 = Videx (ddI, dideoxyinosine, didanosine, Videx EC) 285 = Prezista, Norvir, Emtriva + Viread and Selzentry 216 = Viracept (nelfinavir) blinded trial (ACTG A5303) 191 = Viramune (nevirapine) 264 = raltegravir (Isentress, MK 0518) 058 = Virazole (ribavirin) 194 = Rescriptor (delavirdine) 234 = Viread (adenine fumarate, tenofovir disoproxil) 092 = Retrovir (AZT, zidovudine) 231 = Vistide (cidofovir) 243 = Reyataz (atazanavir) 284 = Vitekta (elvitegravir) 058 = ribavirin (Virazole) 094 = zalcitabine (ddC, dideoxycytidine, Hivid) 276 = rilpivirine (Edurant, TMC 278) 159 = Zerit (d4T, stavudine) 211 = ritonavir (Norvir) 218 = Ziagen (abacavir) 248 = SC 351125 (SCH C) 092 = zidovudine (AZT, Retrovir) 248 = SCH C (SC 351125) 146 = Zovirax (acyclovir) WIHS Drug List 1 – 04/01/2016a Page 2 of 4 WOMEN’S INTERAGENCY HIV STUDY DRUG LIST 1 – BY NUMBER 055 = Isoprinosine 248 = SC 351125 (SCH C) 056 = HPA‐23 (Ammonium‐21‐tung‐9‐anti‐moniate) 249 = Lexiva (fosamprenavir) 057 = suramin 253 = Truvada (tenofovir disoproxil fumarate + 058 = Ribavirin (virazole) emtricitabine, Viread + Emtriva, TDF + FTC) 090 = Alpha interferon 254 = Epzicom (abacabir sulfate + lamivudine, Ziagen + 092 = Retrovir (AZT, zidovudine) Epivir) 094 = Hivid (ddC, dideoxycytidine, zalcitabine) 255 = Intelence (etravirine) 098 = AL‐721 (by Praxis) (egg lecithin) 256 = Prezista (darunavir) 101 = ampligen 257 = L‐00870810 (Merck integrase inhibitor) 108 = Peptide T 258 = SP01A (Samaritan Pharma oral entry inhibitor) 110 = dextran‐sulfate 262 = Atripla (Sustiva + Viread + Emtriva, efavirenz + 122 = beta interferon tenofovir + emtricitabine) 128 = CD4 263 = brecanavir (GW640385) 146 = Zovirax (acyclovir) 264 = Isentress (raltegravir) 147 = Videx (ddI, dideoxyinosine, didanosine, Videx EC) 265 = Selzentry (maraviroc) 159 = Zerit (d4T, stavudine) 266 = vicriviroc (SCH‐417690) 163 = Dideoxyandenosine (ddA) 267 = TMC278 blinded trial 179 = Vidarabine (adenosine arabinoside) 268 = elvitegravir (GS‐9137) blinded trial 191 = Viramune (nevirapine) 269 = vicriviroc blinded trial 192 = TAT inhibitors 276 = Edurant (rilpivirine) 193 = Other protease inhibitors 278 = elvitegravir + cobicistat booster (blinded trial) 194 = Rescriptor (delavirdine) 280 = Complera (emtricitabine + rilpivirine + tenofovir) 204 = Epivir (3‐TC, lamivudine) 282 = cobicistat‐boosted darunavir (blinded trial 207 = Hydrea (hydroxyurea, Droxia) comparing cobicistat‐boosted darunavir to 210 = Invirase (saquinavir, Fortovase) ritonavir‐boosted darunavir) 211 = Norvir (ritonavir) 283 = cobicistat (GS‐9350) 212 = Crixivan (indinavir) 284 = elvitegravir (Vitekta) 216 = Viracept (nelfinavir) 285 = Prezista, Norvir, Emtriva + Viread and Selzentry 217 = Kaletra (lopinavir/ritonavir) blinded trial (ACTG A5303) 218 = Ziagen (abacavir) 286 = Tivicay (dolutegravir) 219 = Agenerase (amprenavir) 287 = Stribild (FTC + Viread + EVG + cobicistat) 220 = Sustiva (efavirenz) 289 = GS‐US‐292‐0102 (EVG + cobicistat + FTC + TAF) 221 = Coactinon (emivirine) blinded trial 222 = lobucavir 290 = Genvoya (EVG + cobicistat + FTC + TAF) 223 = loviride 291 = GS‐US‐299‐0102 (DRV + cobicistat + FTC + TAF) 224 = Preveon (adefovir) 292 = GS‐US‐216‐0130 (DRV + cobicistat + 2 NRTIs) 227 = Combivir (AZT + 3TC, Retrovir + Epivir) 293 = Triumeq (DTG + ABC + 3TC) 231 = Vistide (cidofovir) 294 = GS‐US‐311‐1089 (blinded FTC + TDF or FTC + TAF) 233 = Fuzeon (T‐20, enfuvirtide, ENF) 295 = Prezcobix (darunavir + cobicistat) 234 = Viread (tenofovir disoproxil, adenine fumarate) 296 = Evotaz (atazanavir + cobicistat) 238 = Aptivus (tipranavir) 297 = cabotegravir (GSK1265744) 239 = Emtriva (emtricitabine, Corviracil, FTC) 298 = cenicriviroc/EFV 240 = Trizivir (abacavir + zidovudine + lamivudine, ABC + 299 = TMC114IFD3013 AZT + 3TC) 300 = Cabotegravir (GSK1265744) + 243 = Reyataz (atazanavir) Abacavir/lamivudine followed by intramuscular 244 = DPC 083 regimen of Cabotegravir + Rilpirivine (TMC278) WIHS Drug List 1 – 04/01/2016a Page 3 of 4 WOMEN’S INTERAGENCY HIV STUDY DRUG LIST 1 – BY NUMBER 302 = GS‐US‐366‐1160 (FTC + RPV + TAF or EFV + FTC + 306 = Odefsey (FTC + RPV + TAF) TDF (Atripla)) blinded 307 = dolutegravir + lamivudine dual therapy treatment 303 = GS‐US‐366‐1216 (FTC + RPV + TAF or FTC + RPV + 308 = Descovy (FTC + TAF) TDF (Complera)) blinded 998 = Other antiviral 304 = GS‐US‐311‐1717 (ABC + 3TC or FTC + TAF) blinded 999 = Unknown antiviral 305 = tenofovir alafenamide (TAF) WIHS Drug List 1 – 04/01/2016a Page 4 of 4 .

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    4 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us